Purchase Order 75N91019P00421
Award Date 8/6/19
Potential Completion Date 9/30/19
Potential Value $170K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Mountain View, CA 94043, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $25,956.00 firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Takara Bio USA, Inc., a for-profit manufacturer of specialized biomedical products and services. The contract is for the period of February 24, 2016 to July 15, 2016, and does not have a small business set-aside designation. Takara Bio USA, Inc. is a prime contractor providing the National Cancer Institute with research tools...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to Takara Bio USA, Inc. The contract, valued at $24,900.00, is for the provision of ICELL8 service for a one-year period from June 16, 2025 to June 15, 2026. Takara Bio USA, Inc. is a for-profit manufacturer of biomedical products and life sciences research tools, with a focus on...
- The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $189,000.00 firm fixed-price purchase order to Takara Bio USA, Inc., a manufacturer of biomedical goods and life science reagents, to provide a TAKARA ICELL8 CX SINGLE-CELL SYSTEM PLATFORM. This award was designated as a Total Small Business set-aside. The platform will be used in the NIAMS Genomics Technology Section Core Facility to...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Takara Bio USA, Inc., a prominent provider of specialized biomedical products and services to the U.S. federal government. The contract, valued at $2,508.00, is for the supply of various genomics, cell biology, and molecular diagnostics tools, including products such as SmartScribe Reverse Transcriptase, SeqAmp DNA Polymerase, and RetroNectin GMP Grade Reagent. These products...
- This is a $35,231.70 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Takara Bio USA, Inc. for the delivery of SMARTSCRIBE Reverse Transcriptase and SEQAMP DNA Kits. The contract does not have a set-aside designation. Takara Bio USA, Inc. is a for-profit manufacturer of biomedical products and reagents, frequently serving as a prime contractor on NIH, Environmental Protection...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $95,509.00, is for the procurement of one (1) I-DOT 2.0 dispensing system for the preparation of next-generation sequencing (NGS) library preps of T-cell receptors (TCRs) in support of cancer research. The contract was set aside for small businesses, and the prime...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Takara Bio USA, Inc. The contract, valued at $19,975.65, is for the procurement of SMARTSEQ reagents (AMBIS #2226785) to support the agency's biomedical research activities. Takara Bio USA, a prominent manufacturer of specialized life sciences products, has a long-standing relationship with federal...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Takara Bio USA, Inc., a for-profit manufacturer of biomedical products and life sciences research tools. The $11,770.50 contract is for the supply of in vitro diagnostic substances, reagents, test kits, and sets, and is designated as a Total Small Business set-aside. Takara Bio USA has a history of...
- This is a firm-fixed price purchase order awarded by the Department of Health and Human Services' National Cancer Institute (NCI) to Nexcelom Bioscience LLC, a small business, for a Celigo Image Cytometer System. The $159,000 contract supports the NCI's Transplantation Therapy Section within the Experimental Transplantation and Immunology Branch, which focuses on research related to T cell homeostasis, repertoire, function, and regeneration in a transplantation setting. The Celigo system will...
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., for the procurement of a Thermo Fisher Scientific 3500XL Genetic Analyzer. The $189,712.10 contract is to provide a replacement instrument that will fulfill the needs of the NCI's Division of Cancer Epidemiology and Genetics laboratory, which conducts research on the genetic...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) to Takara Bio USA, Inc. The contract is for the SMARTER ICELL8 CX SINGLE-CELL SYSTEM, which is a specialized instrument and reagents for generating next-generation sequencing (NGS) libraries from single cells, including tumor-specific T-cell receptor clonotypes. The $170,100.00 contract supports the NCI's Cancer Center Research (CCR) program and cancer immunotherapy research. Takara Bio USA, Inc. is the sole manufacturer and distributor of this equipment, and there was no set-aside designation for this commercial item acquisition.
Generated 3/23/24, 7:15 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Brand name SMARTer iCELL8 Single-Cell System and reagents | NCI-5291795 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/1 | 5/10/19, 8:17 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $170.1k | 8/6/19 |